KCT0007709已完成未知
Efficacy of Human Gut microbiota-derived consortium complex for irritable bowel syndrome patients: A open-label, prospective, observational study
Hallym University Medical Center-Kangnam0 个研究点目标入组 44 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •patients (19 years or older) who met the Rome IV criteria for the diagnosis of IBS were eligible to participate.
排除标准
- •The exclusion criteria were previous abdominal surgery except appendectomy and Caesarian section, inflammatory bowel syndrome, and concurrent severe illness (cancer, cardiovascular or pulmonary disease). In addition, patients who had used antipsychotics, antibiotics, and probiotics within the two weeks were also excluded.
研究者
相似试验
尚未招募
Unknown
The efficacy of a healthy gut microbiome-based diet tool versus a conventional diet tool for patients with Type 2 diabetes : A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group TrialType 2 diabetes mellitusJPRN-UMIN000050560Sapporo University of Health Sciences100
尚未招募
Unknown
Comparison of Human Gut microbiota-derived consortium complex with rifaximin and rifaximin for irritable bowel syndrome patientsDiseases of the digestive systemKCT0008556Hallym University Medical Center-Kangnam70
招募中
不适用
Investigation on the assocition between atopic dermatitis and obesityDiseases of the skin and subcutaneous tissueKCT0003630Wonkwang University. Iksan Korean Medicine Hospital80
尚未招募
Unknown
Exploratory study of the effect on gut microbiota by ingestion of oligosaccharide.Healthy adultJPRN-UMIN000052735Meiji Co., Ltd.49
已完成
1 期
Assessment of the influence of the gut microbiome on tacrolimus pharmacokinetics in healthy volunteersPharmacokinetic trial in healthy volunteersDRKS00032072niversitätsklinikum Heidelberg, Im Wege der Auftragsverwaltung für die Universität Heidelberg, Medizinische Fakultät Heidelberg20